Developing new drugs that activate the protective arm of the renin–angiotensin system as a potential treatment for respiratory failure in COVID-19 patients

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has reached pandemic proportions with negative impacts on global health, the world economy and human society. The clinical picture of COVID-19, and the fact that Angiotensin converting enzyme 2 (ACE2) is a receptor of...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Drug Discov Today
Prif Awduron: Latil, Mathilde, Camelo, Serge, Veillet, Stanislas, Lafont, René, Dilda, Pierre J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Elsevier Ltd. 2021
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7888990/
https://ncbi.nlm.nih.gov/pubmed/33609783
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drudis.2021.02.010
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg